Combined General Shareholder Meeting of

Combined General Shareholder Meeting of May 4, 2012

Paris, France May 4, 2012 Sanofi (EURONEXT : SAN et NYSE : SNY) announced its Combined General Shareholder Meeting was held today at the Palais des Congr s in Paris. All

resolutions were adopted by its shareholders.

During the meeting, shareholders approved, among other resolutions, the

corporate and consolidated financial statements for the year 2011. At the General Meeting, shareholders decided the distribution of a dividend in the amount of 2.65 per share that will be detached on Euronext Paris on May 10, 2012

with payment as of May 15, 2012.

The General Meeting also approved the appointment of Mr. Laurent Attal as a

director for a term of four years, i.e., until the General Meeting called to approve the financial statements for the year 2015. Finally, Mr. Uwe Bicker, Mr. Jean-Ren Fourtou, Ms. Claudie Haigner , Ms. Carole

Piwnica and Mr. Klaus Pohle have each been reappointed for a term of four years.

After the Shareholder Meeting, the

Board of Directors is comprised as follows:

During the meeting, the shareholders approved the appointment of statutory and deputy auditors. The

shareholders additionally ratified the move of the registered headquarters of Sanofi to 54, rue La Bo tie, 75008 Paris. During the Board of Directors session following the meeting, Mr. Klaus Pohle was renewed as Chairman of the Audit

The voting results will be available on the company s website (www.sanofi.com) in the

The audiocast of the Combined General Shareholder Meeting is available on the Company s website

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi has core strengths in the field of healthcare with

seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).